Aptuit, LLC has acquired Exquiron Biotech AG, a specialist Contract Research Organization dedicated to early phase drug discovery services.   Located near Basel, Switzerland, Exquiron offers assay development for hit finding and profiling, high throughput screening, selectivity testing and hit characterization. The company also has an extensive library collection of lead like compounds, as well as scientific knowledge in compound selection and Structure Activity Relationship (SAR) expansion ac...